Provocative growth hormone testing in children: how did we get here and where do we go now?

被引:16
|
作者
Kamoun, Camilia [1 ]
Hawkes, Colin Patrick [1 ,2 ]
Grimberg, Adda [1 ,2 ]
机构
[1] Childrens Hosp Philadelphia, Div Endocrinol & Diabet, 3500 Civ Ctr Blvd, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
关键词
children; growth hormone assay; growth hormone deficiency; growth hormone stimulation tests; provocative growth hormone testing; 24-HOUR INTEGRATED CONCENTRATION; IDIOPATHIC SHORT STATURE; BODY-MASS INDEX; STIMULATION TESTS; PREPUBERTAL CHILDREN; HGH DEFICIENCY; ORAL CLONIDINE; GH DEFICIENCY; EXERCISE TEST; FACTOR-I;
D O I
10.1515/jpem-2021-0045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Provocative growth hormone (GH) tests are widely used for diagnosing pediatric GH deficiency (GHD). A thorough understanding of the evidence behind commonly used interpretations and the limitations of these tests is important for improving clinical practice. Content: To place current practice into a historical context, the supporting evidence behind the use of provocative GH tests is presented. By reviewing GH measurement techniques and examining the early data supporting the most common tests and later studies that compared provocative agents to establish reference ranges, the low sensitivity and specificity of these tests become readily apparent. Studies that assess the effects of patient factors, such as obesity and sex steroids, on GHtesting further bring the appropriateness of commonly used cutoffs for diagnosingGHDinto question. Summary and Outlook: Despite thewidely recognized poor performance of provocative GH tests in distinguishing GH sufficiency from deficiency, limited progress has beenmade in improving them. New diagnostic modalities are needed, but until they become available, clinicians can improve the clinical application of provocative GH tests by taking into account the multiple factors that influence their results.
引用
收藏
页码:679 / 696
页数:18
相关论文
共 38 条
  • [1] Latex Allergy: Where Are We Now and How Did We Get There?
    Kelly, Kevin J.
    Sussman, Gordon
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (05) : 1212 - 1216
  • [2] Secondary findings: How did we get here, and where are we going?
    Ormond, Kelly E.
    O'Daniel, Julianne M.
    Kalia, Sarah S.
    JOURNAL OF GENETIC COUNSELING, 2019, 28 (02) : 326 - 333
  • [3] Treating sexual offenders: how did we get here and where are we headed?
    Hanson, R. Karl
    JOURNAL OF SEXUAL AGGRESSION, 2014, 20 (01) : 3 - 8
  • [4] Increased Survival of Congenital Heart Disease How Did We Get Here and Now What?
    Williams, Roberta G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (01) : 45 - 46
  • [5] What do we do now that the long-acting growth hormone is here?
    Miller, Bradley S.
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [6] Disparities in Pediatric Palliative Care: Where Are We and Where Do We Go from Here?
    Boyden, Jackelyn Y.
    Umaretiya, Puja J.
    D'Souza, Louise
    Johnston, Emily E.
    JOURNAL OF PEDIATRICS, 2024, 275
  • [7] Orbital retinoblastoma: Where do we go from here?
    Ali, Mohammad Javed
    Reddy, Vijay Anand P.
    Honavar, Santosh G.
    Naik, Milind
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2011, 7 (01) : 11 - 14
  • [8] Therapy for osteosarcoma: Where do we go from here?
    Chou A.J.
    Geller D.S.
    Gorlick R.
    Pediatric Drugs, 2008, 10 (5) : 315 - 327
  • [9] Pediatric Delirium: Where Do We Go From Here?
    Vats, Atul
    PEDIATRIC CRITICAL CARE MEDICINE, 2018, 19 (10) : 992 - 993
  • [10] Developmental Dyslexia: Where Do We Go from Here?
    Engelhardt, Paul E.
    BRAIN SCIENCES, 2020, 10 (03)